These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38413071)

  • 1. [Research on the framework of biosafety standards for pathogenic microbial laboratories].
    Li J; Chen Z; Li SS; Lu B; Zhao SQ; Wang R; Cao GQ; Wang W; Ma CT; Hou XX; Wang YH; Zhao CH; Wu GZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):294-299. PubMed ID: 38413071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
    Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory.
    Pentella MA
    Clin Lab Med; 2020 Dec; 40(4):473-482. PubMed ID: 33121616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why the world has no universal biosafety standards.
    Silver A
    BMJ; 2022 Apr; 377():o954. PubMed ID: 35422433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biosafety risk of laboratory-acquired infection and countermeasures based on human factors].
    Zuo KL; Jiang T; Wu ZZ; Guo YY; Liu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Aug; 44(8):1309-1315. PubMed ID: 37661626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT; Yadav PD; Khare A; Khan AH
    Indian J Med Res; 2017 Oct; 146(4):459-467. PubMed ID: 29434059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosafety Level 4 Laboratory User Training Program, China.
    Xia H; Huang Y; Ma H; Liu B; Xie W; Song D; Yuan Z
    Emerg Infect Dis; 2019 May; 25(5):. PubMed ID: 31002302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
    Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
    Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory Focus on Improving the Culture of Biosafety: Statewide Risk Assessment of Clinical Laboratories That Process Specimens for Microbiologic Analysis.
    Munson E; Bowles EJ; Dern R; Beck E; Podzorski RP; Bateman AC; Block TK; Kropp JL; Radke T; Siebers K; Simmons B; Smith MA; Spray-Larson F; Warshauer DM
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29118166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication.
    Dickmann P; Apfel F; Biedenkopf N; Eickmann M; Becker S
    Health Secur; 2015; 13(2):88-95. PubMed ID: 25813975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interpretation for the group standards in the handling of accidental leak coronavirus disease 2019 sample].
    Chen M; Mu XQ; Zhang XA; Li J; Zhao R; Chen LJ; Lin CY; Zhao SJ; Liu YZ; Zhang DT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1378-1380. PubMed ID: 33076587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO Laboratory Biosafety Manual: A New Approach to Security.
    Ficociello B; Giordano D; Incoronato F; Farinella A; Pietrangeli B
    Ann Work Expo Health; 2023 Apr; 67(4):425-429. PubMed ID: 36495279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and future challenges of high-level biosafety laboratories in China.
    Zhiming Y
    J Biosaf Biosecur; 2019 Sep; 1(2):123-127. PubMed ID: 32501434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosafety protection and workflow of clinical microbiology laboratory under COVID-19: A review.
    Zhou W; Zou L; Zhu F; Yang J
    Medicine (Baltimore); 2022 Nov; 101(45):e31740. PubMed ID: 36397385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of biosafety precautions in Khartoum state diagnostic laboratories, Sudan.
    Elduma AH
    Pan Afr Med J; 2012; 11():19. PubMed ID: 22514753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Aspects and Considerations When Planning a New Clinical Microbiology Laboratory.
    Hardy DJ
    Clin Lab Med; 2020 Dec; 40(4):421-431. PubMed ID: 33121612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market entry system considering the biosafety of nanomedical devices in China.
    Wen H; Yang Y; Geng X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1821. PubMed ID: 36416024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a biosafety plan for a flow cytometry shared resource laboratory.
    Back JB; Martinez L; Nettenstrom L; Sheerar D; Thornton S
    Cytometry A; 2022 May; 101(5):380-386. PubMed ID: 35037390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytometry in High-Containment Laboratories.
    Cohen M; Laux J; Douagi I
    Methods Mol Biol; 2024; 2779():425-456. PubMed ID: 38526798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.